SiteOne
Edit

SiteOne

https://www.siteonetherapeutics.com/
Last activity: 11.05.2021
Categories: BioTechDiagnosticsInformationManagementPetProductTechnologyUniversity
SiteOne Therapeutics, in Bozeman, MT, was founded on technology invented at Stanford Univ. that represents a revolutionary advancement in the treatment of acute and chronic pain. The company’s therapeutic candidates are highly selective sodium ion channel 1.7 (Naᵥ1.7) inhibitors. Given the critical role Naᵥ1.7 plays in generating pain signals, and the need for new, non-opioid pain therapies, SiteOne is focused on advancing its lead product for the treatment of moderate to severe pain.
Mentions
6
Location: United States, Montana, Bozeman
Employees: 11-50
Total raised: $1.73M
Founded date: 2010

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
11.05.2021Grant$1.73M-

Mentions in press and media 6

DateTitleDescriptionSource
11.05.2021SiteOne Therapeutics Announces $1.73M Grant from NIH/NHLBI a... SOUTH SAN FRANCISCO, Calif., May 11, 2021 /PRNewswire/ -- SiteOne Therapeutics, Inc., a clinical-s...prnewswire...
11.05.2021SiteOne Therapeutics : Announces $1.73M Grant from NIH/NHLBI...SOUTH SAN FRANCISCO, Calif., May 11, 2021 /PRNewswire/ -- SiteOne Therapeutics, Inc., a clinical-sta...marketscre...
20.04.2021SiteOne Therapeutics Announces Initiation of Phase 1 Clinica... SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/ -- SiteOne Therapeutics, Inc., a clinical...prnewswire...
09.01.2017SiteOne Therapeutics Bags $15M Series B BOZEMAN, MT, SiteOne announced the formal closing of a $15 million series B round of financing, le...vcnewsdail...
09.01.2017 Amgen Leads Investment In SiteOne Therapeutics Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-ba...socaltech....
08.01.2017SiteOne Therapeutics Closes $15M Series B Financing RoundSiteOne Therapeutics, a Bozeman, Montana – based developer novel pain therapeutics and diagnostics t...finsmes.co...

Reviews 0

Sign up to leave a review

Sign up Log In